Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Pharmaron, a Beijing CRO, Announces Partnership with AstraZeneca

publication date: Oct 14, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Pharmaron, China’s third-largest CRO, announced a multi-year drug discovery partnership with AstraZeneca that will support AstraZeneca’s global Innovative Medicines Units. Pharmaron will have a dedicated staff of several hundred scientists working on AstraZeneca projects at the CRO’s new facilities in Beijing. The agreement calls for Pharmaron to provide AstraZeneca with discovery services and efficacy screening. More details....

Stock Symbol: (NYSE: AZN)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
ChinaBio® Events
CBPF2016
Suzhou, China
May 18 - 19, 2016
Record attendance of 1008!
See us next year in Shunde!

>> More events...

Other Events
Hong Kong, China
June 15–17, 2016
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors